These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25255986)

  • 1. Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study.
    Goh LG; Welborn TA; Dhaliwal SS
    BMC Womens Health; 2014 Sep; 14():118. PubMed ID: 25255986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
    Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; May M; Brindle P
    BMJ; 2007 Jul; 335(7611):136. PubMed ID: 17615182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Minhas R; Sheikh A; Brindle P
    BMJ; 2008 Jun; 336(7659):1475-82. PubMed ID: 18573856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
    Collins GS; Altman DG
    BMJ; 2012 Jun; 344():e4181. PubMed ID: 22723603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study.
    Chia YC; Gray SY; Ching SM; Lim HM; Chinna K
    BMJ Open; 2015 May; 5(5):e007324. PubMed ID: 25991451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort.
    Hua X; McDermott R; Lung T; Wenitong M; Tran-Duy A; Li M; Clarke P
    Eur J Prev Cardiol; 2017 Oct; 24(15):1660-1669. PubMed ID: 28749178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
    Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
    Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central obesity and cigarette smoking are key determinants of cardiovascular disease deaths in Australia: a public health perspective.
    Dhaliwal SS; Welborn TA
    Prev Med; 2009; 49(2-3):153-7. PubMed ID: 19660494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
    Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
    Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.
    de Ruijter W; Westendorp RG; Assendelft WJ; den Elzen WP; de Craen AJ; le Cessie S; Gussekloo J
    BMJ; 2009 Jan; 338():a3083. PubMed ID: 19131384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2013 May; 346():f2573. PubMed ID: 23641033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
    Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
    N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk prediction tools for populations in Asia.
    ; Barzi F; Patel A; Gu D; Sritara P; Lam TH; Rodgers A; Woodward M
    J Epidemiol Community Health; 2007 Feb; 61(2):115-21. PubMed ID: 17234869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study.
    Al-Shamsi S; Govender RD; King J
    BMJ Open; 2020 Oct; 10(10):e040680. PubMed ID: 33115904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Framingham risk score for prediction of cardiovascular diseases: a population-based study from southern Europe.
    Artigao-Rodenas LM; Carbayo-Herencia JA; Divisón-Garrote JA; Gil-Guillén VF; Massó-Orozco J; Simarro-Rueda M; Molina-Escribano F; Sanchis C; Carrión-Valero L; López de Coca E; Caldevilla D; López-Abril J; Carratalá-Munuera C; Lopez-Pineda A;
    PLoS One; 2013; 8(9):e73529. PubMed ID: 24039972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Framingham stroke risk function in a large population-based cohort of elderly people: the 3C study.
    Bineau S; Dufouil C; Helmer C; Ritchie K; Empana JP; Ducimetière P; Alpérovitch A; Bousser MG; Tzourio C
    Stroke; 2009 May; 40(5):1564-70. PubMed ID: 19286599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the Framingham coronary heart disease risk score for predicting 10-year cardiac risk in adult United Arab Emirates nationals without diabetes: a retrospective cohort study.
    Al-Shamsi S
    BMC Fam Pract; 2020 Aug; 21(1):175. PubMed ID: 32847496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.
    Collins GS; Altman DG
    BMJ; 2009 Jul; 339():b2584. PubMed ID: 19584409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age.
    Scheltens T; Verschuren WM; Boshuizen HC; Hoes AW; Zuithoff NP; Bots ML; Grobbee DE
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):562-6. PubMed ID: 18756178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.